Wegovy Shortage Update June 2024

Wegovy Shortage Update June 2024. This new drug, semaglutide, was first approved for diabetes in 2017 under the brand name ozempic and then in 2021 for weight loss as wegovy. Danish pharmaceutical giant novo nordisk will boost supplies of its wildly popular obesity drug wegovy in the united states this year, mitigating—but likely not.

Sales of novo nordisk’s obesity drug wegovy slowed over the first three months of 2024, compared to the fourth quarter last year, as lower realized prices and. Shortages of the weight loss drug prompted the drugmaker to restrict the supply of the lowest.